Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.

NCT01735084 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT01735084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01735084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.
Lead sponsor
Menzies School of Health Research
Phase
Phase 4
Overall status
Completed
Start date
March 12, 2013
Completion date
October 3, 2019
Enrollment
261 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cough, febrile illness, lower respiratory tract infection, otitis media, upper respiratory tract infection